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Predictors and outcomes of rght ventricular outflow tract conduit
rupture during percutaneous pulmonary valve implantation: a multi-
centric study
Younes Boudjemline (1), Sophie Malekzadeh-Milani (1), Jean-Benoit
Thambo (2), Damien Bonnet (1), Laurence Iserin (3), Alain Fraisse (4)
(1) Hôpital Necker Enfants Malades, Cardiologie pédiatrique, Paris, France
– (2) CHU Bordeaux, Pessac, France – (3) Hôpital Européen Georges Pom-
pidou (HEGP), Paris, France – (4) Hôpital la Timone, Marseille, France
Aims: Conduit rupture is a serious complication encountered during percu-
taneous pulmonary valve implantation (PPVI). We sought to evaluate the inci-
dence and predictors of conduit rupture during right ventricular outflow tract
(RVOT) transcatheter treatment.
Methods and Results: All consecutive patients who underwent transcatheter
RVOT treatment from May 2008 to December 2011 were prospectively studied.
Baseline demographics along with incidence, predictors and outcomes of
conduit rupture with various transcatheter therapies were reviewed. Conduit
rupture occurred in 9 out of 99 patients (9.09%). All conduit ruptures occurred
universally during balloon dilatation. Significant risk factors included heavy cal-
cification (p<0.05, OR=16 [1.87-357]), conduit type (homograft/others; p<0.05,
OR=5.37 [1.1-27.39]) and conduit stenosis as the primary lesion (p<0.05). Other
factors such as prolonged time interval between prior surgical RVOT repair and
interventions, use of high-pressure balloons, balloon diameter, and overexpan-
sion of conduit statistically failed to show any association. All patients were
managed in the cardiac catheterization laboratory. There were no delayed com-
plications during a mean follow up period of 2.3±0.95 years. 
Conclusion: Conduit rupture is a serious complication. Heavy calcifica-
tion, homograft conduit and stenosis as primary lesion were significant predic-
tors. Immediate diagnosis with use of targeted interventional therapies should
be attempted before proceeding with PPVI. 
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Characterization of right ventricular activation in patients with tetra-
logy of fallot and right bundle branch block
Zakaria Jalal(1), Frederic Sacher (2), Pierre Bordchar (2), Nicolas Derval
(2), Sylvain Ploux (2), Michel Haïssaguerre (2), Pierre Jais (2), Jean-
Benoit Thambo (1)
(1) C.H.U Bordeaux, Cardiopathie congénitales – Dr.Thambo, Pessac,
France – (2) CHU Bordeaux, Rythmologie et stimulation cardiaque, Pes-
sac, France
Introduction: Presence of prolonged QRS duration in patients with
tetralogy of Fallot (TOF) is considered as a risk factor for sudden death and a
possible target for CRT. We characterized the RV activation pattern in these
patients to better understand the electrophysiological background for arrhyth-
mias and RV dysfunction.
Methods: RV activation sequence was studied in 28 adults (QRSd
153±21ms) referred for either catheter ablation or pulmonary valve replace-
ment late after ToF repair, with application of 3D contact mapping
(201•32 sites per patient; Carto 3 – Biosense Webster).
Results: Activation maps showed a single RV breakthrough in the septum
recorded 28•23ms after the beginning of the earliest QRS complex (slow left-
to-right transseptal activation time and absence of direct RV Purkinje activa-
tion).Two distinct patterns of activation proceeded from the breakthrough site:
1) the first one from the septum to the outflow tract and to the RV free wall;
we observed, at the level of the RVOT, presence of fragmented, low voltage
potentials corresponding to the surgical scars and patches; 2) the second one,
from the septum to the apex and the mid RV free wall with prolonged
conduction velocities likely as a result of cell-to-cell conduction (figure 1).The
RV activation ended at the mid portion of the RV free wall after a mean RV
activation time of 127•20ms.RV activation time was correlated to QRSd
(r=0,72; p<0,001) and with MRI RV end diastolic volume (r=0,67, p<0,001).
Conclusion: RV activation in TOF patients is a complex process involving
anatomic, heamodynamic and electro physiologic parameters. This may have
important implications in the understanding of the risk of sudden death and in
the determination of the optimal resynchronization pacing sites.
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Incidence and predictors of melody valve endocarditis: a prospective
study
Sophie Malekzadeh-Milani (1), Magalie Ladouceur (1), Fazia-Marie
Boughenou (2), Laurence Iserin (2), Damien Bonnet (1), Younes Boud-
jemline (1)
(1) Hôpital Necker Enfants Malades, Cardiologie pédiatrique, Paris,
France – (2) Hôpital Européen Georges Pompidou (HEGP), Paris,
France
Aims: Percutaneous pulmonary valve replacement (PPVI) has achieved
standard of care for the management of dysfunctional right ventricular outflow
tract. There are increasing reports of infective endocarditis (IE). We sought to
evaluate the incidence and predictors of Melody valve endocarditis.
Methods and Results: A systematic review of patients who received
Melody valve from 2009 to 2012 was performed. The infective events were
studied and the potential risks factors identified. A total of 86 consecutive
patients underwent PPVI during the study period; of these 5 developed IE
(5.8%, 95%CI [0.9-10.7%]). In the group of patients with IE, mean duration
of onset of IE was 14.8 months. The baseline demographics, type of conduit,
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Figure 1 –  Anterior and posterior views of RV activation maps (A and C) and  
RV voltage maps (B and D) in the same patient (RVOT=right ventricular 
outflow tract , VSD=ventricular septal defect, IVS=interventricular septum, 
TA=tricuspid annulus, PA=pulmonary annulus). 
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PPVI procedural success, residual gradients and in-situ duration of Melody
valve were comparable in both groups with and without IE. Microbial diag-
nosis was achieved in all and probable source of infection and its portal of
entry were identified in 4/5 cases. A significant number of patients with IE
however had abruptly discontinued antiplatelet therapy (3/5, p=0.026, RR=20
[3.34-120.8]). Three patients presented with severe obstruction, of whom
2 died within 24 hours while on medical therapy and one required urgent bal-
loon angioplasty to relief obstruction. 
Conclusion: Early and late onset, de novo prosthetic valve endocarditis of
the melody valve is emerging as a catastrophic complication of PPVI. Abrupt
aspirin discontinuation turns out to be a significant predictor of Melody valve
endocarditis. Due to its rapidly progressive nature, aggressive invasive man-
agement should not be delayed.
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Atrial septal defect area assessed by 3D echo is relevant for calibra-
tion during percutaneous closure.
Sébastien Hascoët (1), Khaled Hadeed (2), Pauline Marchal (2), Francois
Heitz (3), Marianne Peyre (2), Xavier Alacoque (4), Gérald Chausseray (4),
Yves Dulac (2), Rose Fesseau (4), Philippe Acar (2)
(1) CHU Toulouse, Hôpital des enfants, Pediatric cardiac surgery, Tou-
louse, France – (2) CHU Toulouse, Hôpital des enfants, Pediatric cardio-
logy, Toulouse, France – (3) Clinique Pasteur, Pediatric cardiology,
Toulouse, France – (4) CHU Toulouse, Hôpital des enfants, Anesthésie
cardiopédiatrique, Toulouse, France
Balloon Sizing during percutaneous atrial septal defect (ASD) closure
extends radiation dose and device size but remains the gold standard. We
assessed the relationship between the occlusive balloon diameter (BD), area
and diameters measured using real timeTransEsophagealEchocardiography
(RT3DTEE) and the effect of ASD shape.
Methods: From 2011 to 2013, we prospectively enrolled 30 children (mean
weight 30.9kgs max64 min18) who underwent transcatheter closure of an iso-
lated ASD under 3DTEE (3D-matrix array 2-7 MHz TEE probe and iE33 US
machine Philips®). ASD diameters were measured by 2D-TEE and off-line by
3D Multiplanar reconstruction (Qlab software®). ASD area was estimated by
delineating the outlines of the defect on the reconstruction software. The shape of
the ASD was assessed visually on the RT3DTEE “en face” view and was defined
as circular (n=16) or ovale (n=14). An asymmetry index was calculated by the
maximal divided by the minimal 3D diameter (mean 1.4±0.2 min1 max1.84). A
cut-off of 1.25 was set to distinguish ovale (n=8) and circular shape (n=22). 
Results:.The Amplatzer® device number was equal to BD±1mm in
23 cases (76.7%) and higher in the remaining cases. Difference between 3D
maximal diameter and BD (2.3±4.2mm min-9.6 max12.2, p=0.0051) was
higher in round ASD than in ovale shape (4.8±3.5 vs 1.4±4.1, p=0.04). ASD
area was well correlated with BD (r=0.82, p<0001). After multivariate linear
regression analysis, ASD area by 3D delineation was the only significant vari-
able for the prediction of BD: BD (mm)= 4.5*ASD area (cm2)+11. This for-
mula allow a prediction with <1mm difference with the observed BD in ½ and
<=2mm in 2/3 of procedures.
Conclusion: The relationship between BD and echo parameters is influ-
enced by the ASD shape. ASD area estimated by delineation on a 3D view is
the most relevant parameter to estimate the BD. It may be sufficient to guide
percutaneous ASD closure without balloon sizing in children.
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tien Hascoet (7), Laurianne Le Gloan (1), Karine Warin Fresse (1), Patrice
Guérin (1)
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Lannelongue, Le Plessis Robinson, France – (3) Hôpital Necker Enfants
Malades, Paris, France – (4) Institut cardiovasculaire Paris Sud, Massy,
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Background: prevalence of coronary fistulas is poorly known in the
pediatric population. However complications are potentially serious with:
heart failure, sudden death, arrhythmias, endocarditis. In adults, trans-
catheter closure is an alternative to surgical treatment. In pediatric popu-
lation, few publications exist on the feasibility and effectiveness of this
treatment.
Aims: To evaluate the feasibility of percutaneous closure of coro-
nary fistulae in paediatrics, the evolution and the occurrence of complica-
tions.
Methods: Retrospective observational multicentric national study
concerning all patients under 16 who underwent transcatheter closure of a
congenital coronary fistula (complex cardiopathies excluded).
Results: 
ORIGIN Left coronary (28) Right coronary (28) Double (5)
DRAINAGE SITE Right atrium (12)
Right ventricle (12)
Left atrium (2)
Left and right ventricle (1)
Pulmonary artery (1) Right atrium (12)
Right ventricle (13) 
Pulmonary artery (2)
Left atrium (1) Right ventricle (4)
Pulmonary artery (1)
Population: 61 patients (36 girls, 25 boys), median age at diagnosis
0,6 years [0-15,4], 3,9 years at procedure [0-16].
Initial signs: precordial murmur (90%), congestive heart failure (11%), non
specific ECG abnormalities (4,9%), left or right ventricular dilatation (31%).
Efficiency: complete occlusion at hospital discharge in 82%, 5 procedures
failures.
Complications: no death. 3 transient STEMI, 3 Coil embolization, 1 ven-
tricular fibrillation recovered, 1 Leg ischemia.
Combination therapy: antiplatelet (46%), mean duration 4.1 months. 1 with
AVK treatment 
Evolution: data are available for 43 children (70%), median follow-up 91
days[min=0, max=4824]. At 2 years, complete occlusion rate was
72.7%±7.6%.
5 reoperations (3 transcatheter, 2 surgical procedures). 1 late recanalization
at 17 months.
No cardiovascular complication.
Conclusion: the percutaneous closure of coronary fistulas in the pediatric
population appears to be effective and relatively safe. 
Figure – Right coronary to right atria fistula
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Management and transcatheter therapy in partial abnormal pulmo-
nary venous return with additional drainage to the left atrium: a mul-
ticenter study and world experience
Deborah Luciano (1), Daniella Laux (2), Younes Boudjemline (2), Philippe
Aldebert (1), Sebastien Hascoet (3), Jean René Lusson (4), Clio Sorensen
(1), Caroline Ovaert (1), Bernard Kreitmann (1), Alain Fraisse (1)
(1) Hôpital la Timone enfants, Cardiologie pédiatrique, Marseille, France –
(2) Hôpital Necker-Enfants-Malades, Centre de malformation Cardiaques
Congenitales Complexes, Paris, France – (3) CHU Rangueil, Toulouse,
France – (4) CHU NGM St Jacques, Clermont-Ferrand, France
Backgound: A dormant pulmonary vein connecting a partial abnormal
pulmonary venous return to the left atrium has been occasionally reported.
Indications for transcatheter therapy are not clarified and data on mid-term
results is lacking. We aim to report characteristics and transcatheter therapy in
partial abnormal pulmonary venous return with additional drainage to the left
atrium.
Methods: We retrospectively studied such patients in 5 institutions. 
Results: Ten patients(6 girls) presented at a median age of 8(0.1 to 54)
year-old with 2 anatomic types: 8 vertical vein types (drainage of the left
upper lobe to the innominate vein via a large vertical vein and to the left
atrium via the left upper pulmonary vein) and 2 scimitar vein types (drainage
of the right middle and lower pulmonary veins to the inferior vena cava and
to the left atrium via a connecting pulmonary vein). Associated malformations
were aortic coarctation(n=2) and secundum atrial septal defect(n=3). Two
patients with vertical vein type were operated. Transcatheter occlusion of the
abnormal pulmonary venous return was performed with Amplatzer devices in
7 cases, associated with coil-occlusion of systemic arterial supply(n=2),
secundum atrial septal closure(n=2), left upper pulmonary vein stenosis
stenting(n=1), and coarctation stenting(n=1). Including previously published
cases, 18 patients (13 vertical vein, 5 scimitar vein types) underwent trans-
catheter repair. Patients over 40 year-old tend to be symptomatic at presenta-
tion (p=0.056). 
Conclusion: In partial abnormal pulmonary venous return with dual
drainage, transcatheter therapy can be offered in the majority of the patients
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Quality of life among children with congenital heart diseases: compa-
rative multi-center cross-sectional study.
Pascal Amedro (1), Stephane Moniotte (2), Raphael Dorka (1), S. Guillau-
mont (3), Catherine Barrea (2), Thierry Sluysmans (2), Grégoire De La
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Montpellier, France – (2) Clinique Saint-Luc, Cardiopédiatrie, Bruxelles,
Belgique – (3) Institut Saint-Pierre, Cardiopédiatrie, Palavas-Les-Flots,
France – (4) CHU Arnaud de Villeneuve, Cardiopédiatrie, Montpellier,
France – (5) CHU Montpellier, Epidémiologie et Recherche Clinique,
Montpellier, France – (6) Faculté de Médecine, Laboratoire de Santé
Publique, EA 3279, Marseille, France
Introduction: very few comparative studies have yet reported health
related quality of life (HRQoL) among children with congenital heart diseases
(CHD).
Method: we prospectively recruited children aged 8 to 18 with CHD
(group 1, n=282) and same age randomized control population selected among
schools (group 2, n=164). CHD were recruited in 2 tertiary care centers in
France and Belgium. 30 families refused to participate in group 1 and 150 in
group 2. Primary outcome was the scoring for each dimension with Kidscreen-
52 for children and Kidscreen-27 for parents (French version of the generic
validated pediatric HRQoL questionnaire). Secondary outcomes were: severity
class of CHD from 1 to 4 (from Uzark), cardiopulmonary exercise test
(VO2max, SV1), and PedsQL scoring (non validated HRQoL generic ques-
tionnaire, French and Belgium versions).
Results: 282 children with CHD (sex ratio 1,9 – mean age 12,3±3) and
164 children in schools (sex ratio 1,1 – mean age 12,8±2,4) were recruited.
Both centers were comparable for most demographic and clinical data. In most
dimensions self reported QoL scores among children with CHD were not dif-
ferent from control group, except for physical well-being (mean 46,5±10,2 vs
49,9±8,6, p<0,05). QoL in lower severity classes is not significantly different
from controls. Children with severe CHD (class 4) have lower QoL in phy-
sical well-being (43,34±9,64, p<0,05). In several dimensions (physical, social,
school) parents’ reported QoL is lower than their children’s evaluation in
group 1 but not in group 2 where scorings are identical. Teenagers have higher
QoL scores than younger children.
Conclusion: QoL among children with CHD is close to that of same age
healthy children excepted for physical well-being. HRQoL for low severity
CHD patients is similar to controls. QoL for severe CHD is the most
impacted. Further studies should evaluate QoL evolution in time per patient.
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Quantitative assessment of right ventricular function by 2D speckle
tracking imaging in Eisenmenger syndrome
Imene Hachemaoui, Xavier Iriart, Emmanuelle Guilhon, Zakaria Jalal,
Pierre-Emmanuel Seguela, Jean-Benoit Thambo
CHU Bordeaux, Hôpital cardiologique, Service des cardiopathies congé-
nitales, Pessac, France
Background: 2D strain imaging (2DS) is a reliable non invasive technique
for assessing global and regional right ventricle (RV) function in pulmonary
hypertension (PAH). Eisenmenger syndrome (ES) differs significantly from
other types of PAH (OTPAH) in its physiology and prognosis. Aim: To assess
the RV function by 2DS in ES and determine whether there is a difference
with OTPAH. 
Methods and Results: Clinical and echocardiographic variables were
assessed in 14 consecutive patients with ES (mean age 39±12), and 15 patients
with other types of PAH (mean age 61.1±12). 17 Patients were in functional
class (FC) II (10 ES) and 11patients were in FC III (4 ES). No difference was
found between the 2 groups regarding 6MWTD (p=0.93). mPAP and
PVR were higher in the ES group (71.7±13mmHg vs 41.6±9mmHg, p<0.01
and 12.9±2 vs 8.3±3 UWood, p=0.05). 
Correlation between 2DS and conventional parameters was good (: (TAPSE
[r²=-0.91], FAC [r²=-0,89], RA/LA surface ratio [r²=-0.88], peak systolic
velocity ([r²=-0.84], excentricity index [r²= -0.81 ], Tei index [r²= -0.81]). No
statistical difference was found between ES and OTPAH regarding conven-
tional parameters except for TAPSE (p=0.02,FAC p=0.13, S' p=0.77)),
whereas 2DS showed a markedly less impaired RV function in the ES group
(-18.87±1.66% vs -13.82± 2.89%, p<0.001), even when analysis was adjusted
to FC in each group (p<0.01). 2DS segmental analysis of the RV free wall
showed more pronounced difference in the apical segments (p<0.001) in com-
parison with basal segments (p=0.57) between the 2 groups, emphazing the
importance of RV apical function in PAH. 
Conclusion: 2DS provides a new tool to quantify global and regional
longitudinal RV function in ES. Despite additional cyanosis-related comor-
bidities, the specific pathophysiology and hemodynamic conditions of ES are
associated with relatively preserved RV systolic function which may be part
of the better survival outcome in comparison with OTPAH.
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Aortic root and ascending aortic dilatation in patients with repaired
tetralogy of fallot: determinants, rates of progression and outcomes.
Béatrice Bonello (1), Sonya Babu-Narayan (2), Gerhard Diller (2), Yumi
Shiina (2), Sylvain Beurteuret (3), Mickael Gatzoulis (2), Darryl Shore (2)
(1) CHU la Timone, Marseille, France – (2) Royal Brompton Hospital,
London, Royaume-Uni – (3) Hôpital Saint Jospeh, Marseille, France
Background: We examined the features, progression and relations with
outcomes of aortic dilatation in adults with repaired tetralogy of Fallot (rtoF). 
Methods and results: Retrospective study of 110 rtoF adults with native
aorta, median age 30.9(IQR 22.9-39.4) years were studied by cardiovascular
magnetic resonance (CMR) at baseline, and at follow-up (median 6.3 [IQR
5.1-7.6] years). Aortic diameter was measured at sinus, sino-tubular junction
and mid-ascending aorta level. Aorta dilatation was defined as diameter > 2
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standard deviations larger than normal. Three different phenotypes were
described: 36% had normal aortic dimension at any level (Figure 1A), 42%
had aortic root dilatation (Figure 1B) and 22% had aortic root and ascending
aorta dilatation (Figure 1C). There was no predictor of sinus dilatation, but age
at repair (OR1.1, p=0.004), male gender (OR3.6, p=0.01), pulmonary atresia
(OR17.3, p=0.0007) and previous palliation were predictors of ascending aorta
dilatation. On multivariate analysis, age at repair (p=0.006), male gender
(p=0.008) and pulmonary atresia (p=0.0004) were independent predictors for
ascending aorta dilatation. No patient experienced any aorta related event.
Diameter increase was low: mean rate 0.05 ±0.1 mm/year at sinus and 0.12
±0.26 mm/year ascending aorta level and occurred in 25% of patients at sinus,
and in 35% at ascending aorta level. No predictors of aortic diameter progres-
sion were found. 
Conclusions: There are different phenotypes in aorta in patients with rtoF
and aortic root dilatation is the most common. Rates of diameter increase in
mid-term follow-up are low. This should be taken into account when planning
for imaging in follow-up and/or discussing the merits of prophylactic aortic
replacement.
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The medical past of adults with complex congenital heart disease
impacts their social development and professional activity.
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Advances in surgery and therapeutic catheterization in recent decades
increased steadily life expectancy and prevalence of adult patients with
congenital heart disease (ACHD). We assessed medical and psychosocial
parameters of ACHD according to the complexity of the disease.
Methods: We included from a single-center prospective observational
cohort study which started in January 2013, 68 ACHD patients (40.7±
13.9 years old, max 77) followed in cardiology from January to April 2013
who answer a questionnaire assessing daily activity and psychosocial being.
Complexity of the disease was classified according to the 32nd Bethesda
conference. 
Results: Cardiac malformations were Simple (S) in 30 patients (44.1%),
Moderate (M) in 26 (38.2%) and complex (C) in 12 (17.7%). Paediatric Car-
diac surgery had been performed in 84.2% of M and C patients. Patients were
referred for interventional catheterization (n=12, 17.6%), for surgery (n=5,
7.4%), for acute heart failure (n=3, 4.4%, 100% type C) or for medical follow-
up. Complications (Stroke (n=2/12), heart failure (n=10/12), arrhythmia (n=7/12),
pulmonary hypertension (n=5/12), death (n=1/12)) were mainly observed in C
patients (p=0.018). C and M patients had lower education level (respectively
14.3%, 12.5% vs 55.7% had Baccalaureat, p=0.019). C patients had less
access to driving license (p=0.02). Only 1/3 of C patients had an active
employment. Physical activity was lower in C patients (p=0.02, none activity
in 87.5% but 57% had been previously contra-indicated to sport). There were
no significant differences between the 3 groups regarding antidepressant
medication (8.2%, p=0.578) and psychological follow-up (19.0%). 
Conclusion: ACHD patients with complex heart disease have reached
adulthood as “survivors”. Their medical past has impacted their social devel-
opment and professional activity. A peculiar attention should be worn in the
scholarship of children with complex congenital heart disease.
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Long-term survival and functional status of adult patient with eisen-
menger syndrome
Alexandra Soufi, François Sassolas, André Bozio, Jean Ninet, Olivier
Metton, Roland Henaine, Sylvie Di Fillipo
Hôpital Cardiovasculaire, Cardiologie Pédiatrique et Congénitale, Lyon,
France
In the context of new target therapies, this study aimed to assess the func-
tional status and long-term outcomes of patients with Eisenmenger Syndrome
reaching adulthood.
Material and methods: This is a single-centre retrospective review of all
patients diagnosed with Eisenmenger Syndrome. Demographics, clinical data,
underlying cardiac disease, functional status, therapeutics and outcomes were
collected.
Results: 159 patient were included (94 females: 59%), aged 27.7±
14.8years at end-follow up, and 60 with Down syndrome (38%). Underlying
cardiac disease was: AVSD in 30%, VSD in 35%, ASD in 9%, PDA in 5%,
associated shunts in 5%, complex CHD in 10%, left heart obstruction in
2.5%, pulmonary veins anomaly in 2.5% and TGA in 1%. CHD was native
in 122 cases (77%), 7 had palliation (4%) and 30 complete repair (19%).
Pulse oxygen saturation was 84±12% (range 44 to 98%), lower in non-oper-
ated or palliated cases (81%) than in repaired cases (92%, p= 0.002).
Patients were in NYHA class I (18%), class II (42%), class III (37%) or IV
(3%), not different with previous repair or not. Target therapy agents were
given in 35% of the cases (1 agent in 20%, 2 associated in 13%, intravenous
epoprostenol in 1.5%). Death occurred in 26 patients (16%) at the age of
29.3±17.8years. Complications occurred in most of the cases (64%)
including: hemorrhages events, syncopes, thrombo-embolia, cerebral
abscess, infective endocarditis, heart failure or arrhythmias. NYHA class did
not differ between patients with or without target therapy. SpO2 was 82% in
untreated cases compared to 86% in treated cases (NS). Survival rates were:
98% at 10-years, 93% at 20-years, 87% at 30-years, 83% at 40-years, 73%
at 50-years and 53% at 60-years of follow-up. Survival was lower in Down
patients (p=0.0023), in males (p=0.04) and higher better up to 50-years in
patients under target therapy (p=0.05). 
Conclusion: Survival rates of adult patients with Eisenmenger Syndrome
seem to improve up to 50-year of age with target therapy agents. These results
have to be confirmed by larger scale multicentre studies.
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Is surgical repair of partial atrioventricular septal defect safe and effi-
cient in adulthood? 
Philippe Aldebert (1), Bonello Beatrice (1), Alain Fraisse (1), Sebastien
Hascoet (2), Bernard Kreitmann (1), Loic Mace (1), Caroline Ovaert (1),
Sylvie Schouvey (1), Florent Paoli (1), Aldebert Philippe (1)
(1) Hôpital la Timone enfants, Cardiologie pédiatrique, Marseille, France –
(2) CHU Rangueil, Toulouse, France
Background: partial atrioventricular septal defect (PAVSD) is usually
operated in childhood with excellent long-term results. However, some
patients may present during adulthood and their management as well as their
outcome is still unclear. We sought to analyze the clinical characteristics at
presentation and the outcome of patients with PAVSD, non operated or oper-
ated during adulthood
Figure 1 – Different aorta phenotypes.
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Methods: Between January 2000 and March 2013, 31 adult patients with
PAVSD presented and were followed in our care network. The mean age at
study entry was 34(+16.6) years.
Results: Dyspnea was the most frequent symptom at presentation in
19 cases (61%). Left atrioventricular valve regurgitation (LAVVR) and
right ventricular overload were higher in patients undergoing surgical repair
(p=0.01). Twenty-two patients (71%) had their surgical repair at a mean
age of 39.4(+15.3) year-old with ostium primum closure and partial or
complete suture of the left atrioventricular cleft without postoperative death
or major complication. There was one late reoperation for a residual shunt.
Nine patients(29%) were not operated. After a mean follow-up of 7.4(+7.1)
years, 26 patients(84%) are in NYHA class I or 2 whereas 5(16%) are in
NYHA class III or IV. Operated patients have a lower NYHA class
(p<0.01), a lower grade of LAVVR(p=0.03) and a lower systolic pulmonary
artery pressure(p<0.01) than unoperated patients at last follow-up. The
onset or persistence of supraventricular arythmias(SVA) after surgery was
associated with an older(>40 year-old) age at repair(p=0.02), a higher sys-
tolic pulmonary artery pressure(p=0.04) and a higher grade of LAVVR
(p=0.03). 
Conclusion: PAVSD repair is indicated in the adult patient because it car-
ries an excellent prognosis and operated patients have better long-term clinical
and hemodynamic status than unoperated patients. Moreover, SVA incidence
decreases when surgery is performed before 40 year-old.
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Relationship between fluoroscopic time, morphological parameters
and irradiation during catheterization in children with congenital
heart disease.
Sébastien Hascoët (1), Guillaume Oustau (2), Khaled Hadeed (3), Sebas-
tien Balduyck (2), Francois Heitz (4), Xavier Alacoque (5), Gérald Chaus-
seray (5), Rose Fesseau (5), Yves Dulac (3), Marianne Peyre (3), Philippe
Acar (3)
(1) CHU Toulouse, Hôpital des enfants, Pediatric cardiac surgery, Tou-
louse, France – (2) CHU Toulouse, Radioprotection, Toulouse, France –
(3) CHU Toulouse, Hôpital des enfants, Pediatric cardiology, Toulouse,
France – (4) Clinique Pasteur, Pediatric cardiology, Toulouse, France –
(5) CHU Toulouse, Hôpital des enfants, Anesthésie cardiopédiatrique,
Toulouse, France
Cardiac catheterization procedures are being increasingly performed in
children with congenital heart disease for diagnostic and treatment purposes.
Given children's greater sensitivity to radiation and the longer life span during
which radiation health effects can develop, knowledge of factors associated
with irradiation is necessary. We report the radiation doses and related factors
for children who underwent cardiac catheterization in Toulouse children Hos-
pital from January to April 2013.
Methods and results: we prospectively included 60 consecutive children
(mean age 4 years old, weight 2.350-59 kgs) undergoing a therapeutic (n=55,
91.7%) or diagnostic (n=5, 8.3%) procedure. We investigated the relationship
between Dose Area Product (DAP), Fluoroscopic Time (FT), pulsed Fluoro-
scopic DAP, image acquisition DAP, age, morphological parameters and
double products combining FT and morphological parameters. Body Surface
Area (BSA) was calculated with the Mosteller formula.
The mean DAP was 20697±29342mgycm2. The mean total fluoroscopic
time was 24.6±19.7 min. DAP was not significantly different between diag-
nostic and therapeutic catheterization (p=0.98). Although Image acquisition
DAP accounted for only 4.4±2.4% of FT, it represented 42.5±19.6% of DAP.
DAP was moderately but significantly correlated with FT (r=0.73, p<0.0001),
BSA (r=0.44, p=0.0011), age (r=0.37, p=0.0082), weight (r=0.43, p=0.002)
and size (r=0.38, p=0.0052). DAP was strongly associated with FTxWeight
(r=0.92, p<0.0001),FTxBSA (r=0.93, p<0.0001) and FTxSize (r=0.91,
p<0.0001). Linear regression analysis model involving FTxBSA to predict
DAP was significant (p<0.0001). Approximately 90% of the variance of DAP
was accounted for by this model. 
Conclusion: FT and morphological features (BSA, weight, size) are the
key parameters associated with DAP. Peculiar attention to reduce FT and
avoid unnecessary image acquisition may decrease irradiation during catheter-
ization in children with congenital heart disease.
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A 10-year study of planed delivery of foetuses with prenatally diag-
nosed congenital heart disease
Myriam Bensemlali, Francesca Raimondi, Fanny Bajolle-W, Jerome
Le Bidois, Marilyne Lévy, Laurent Fermont, Damien Bonnet
Hôpital Necker Enfants Malades, M3C, Cardiologie Congénitale et Pédia-
trique, Paris, France
Objectives: To describe the aims and rationale for planned delivery in a
tertiary referral centre for foetuses with prenatal diagnosis of congenital heart
disease.
Methods and results: 2130 consecutive foetuses with congenital heart
disease diagnosed from January 2002 to December 2011 were included:
1258 (59%) in-born neonates whose delivery was planned in our institution,
799 (38%) terminations of pregnancy, and 73 (3%) foetal deaths. For in-
born, planed delivery was classified as ‘certainly justified' for 899 (71%) for
the following reasons: Rashkind atrioseptotomy in 344 cases, risk of aortic
coarctation in 272 cases, ductal patency needed for pulmonary flow in
107 cases, ductal patency needed for systemic flow in 93 cases, need for an
immediate intervention in 83 cases. For the remaining 359 in-born, planed
delivery was classified as ‘potentially justified' for the following reasons:
possible need for ductal patency for pulmonary flow in 156 cases, for sys-
temic flow in 35 cases (3%), incomplete congenital heart disease diagnosis
in 94 cases, need to monitor neonatal tolerance of the defect in 51 cases. In
these 359 in-born at risk, rationale for planed delivery was reviewed after
birth. A posteriori, it was not necessary for 249 in-born (20%) in whom no
intervention was needed during the first week, and confirmed to be neces-
sary for 110 in-born (9%) – 32 in whom diagnosis was different with a
direct influence on management and with 78 who needed an intervention
during the first week. 
Conclusions: Our study demonstrates that only a fifth of foetal congenital
heart diseases delivered in a tertiary reference centre appear to be unnecessary.
Conversely, a third of in-born with only possible post-natal risk of cardiac
complication were appropriately delivered in our institution, as they needed
immediate specialized management.
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Natural history of Barth syndrome. A national cohort study of 22 patients
Charlotte Rigaud (1), Anne-Sophie Lebre (2), Renaud Touraine (3),
Blandine Beaupain (1), Chris Ottolenghi (4), Marlene Rio (2), Philippe
Charron (5), Hélène Ansquer (6), Catherine Vaillant (7), Sylvie Di Filippo (8),
Jean Donadieu (1), Damien Bonnet (9)
(1)Hôpital Trousseau, Registre français des neutropénies chroniques
sévères, Service d’Hémato-oncologie Pédiatrique, Paris, France –
(2) Hôpital Necker Enfants Malades, Département de Génétique Paris,
France – (3) Centre Hospitalo-Universitaire Saint Etienne, Service de
Génétique, Saint Etienne, France – (4) Hôpital Necker Enfants Malades,
Paris, France – (5) Hôpital La Pitié-Salpêtrière, Centre de référence pour
les maladies cardiaques héréditaires, Paris, France – (6) CHU Brest,
Cardiologie Pédiatrique, Brest, France – (7) CHU Tours, Cardiologie
pédiatrique, Tours, France – (8) CHU Lyon, Cardiologie congénitale et
pédiatrique, Lyon, France – (9) Hôpital Necker Enfants Malades, M3C,
Cardiologie Congénitale et Pédiatrique, Paris, France
Objective: This study aims to describe the natural history of Barth Syn-
drome (BTHS).
Methods: Clinical and biological files of all patients with BTHS living in
France identified from multiple sources were reviewed.
Results: We identified 16 BTHS pedigrees that included 22 patients, and
14 different TAZ mutations. Estimated incidence for BTHS was of 1.5 per
millions births. Median age at diagnosis was 3.1 weeks and median age at last
follow-up for living patients was 4.75 years (range 3– 15 years). Eleven
patients died at a median age of 5.1 months. The 5-year survival was 49% and
no death was observed above the age of 3 years. Cardiomyopathy was the pre-
senting symptom in 14 patients. Overall 20 patients had symptomatic cardio-
myopathy that causes death in 9/11 patients. Left ventricular systolic function
was very poor during the first year of life and trends to normalize when
© Elsevier Masson SAS. All rights reserved.
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patients grew up. Neutropenia was found in nineteen patients. It was respon-
sible for eight episodes of severe infection including three septic shocks
causing death in two cases. Survival correlates with two prognostic factors:
the severe neutropenia at diagnosis (<0.5 G/L) and the year of birth, as
patients born after 2000 had a 70% survival rate vs 22% for those birth before
2000.
Conclusion: BTHS outcome in this survey is driven by cardiac events and
with the infectious risk related to neutropenia. Intensive treatment of heart
failure and prevention of infection in infancy may improve survival of patients
with BTHS.
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Incidence, diagnosis and outcomes of coronary artery compression
during percutaneous pulmonary valve implantation
Alain Fraisse (1), Anass Assaidi (2), Lucia Mauri (1), Jean Benoit
Thambo (3), Sophie Malekzadeh-Milani (4), Philippe Aldebert (2), Damien
Bonnet (4), Mehul Patel (4), Laurence Iserin (4), Younes Boudjemline (4)
(1) Hôpital la Timone, Marseille, France – (2) Hôpital la Timone enfants,
Marseille, France – (3) CHU Bordeaux, Bordeaux, France – (4) Hôpital
Necker Enfants Malades, Paris, France
Background: Coronary compression (CC) may occur during percutaneous
pulmonary valve implantation (PPVI) and is potentially life threatening. We
sought to evaluate its incidence, diagnosis and outcome.
Methods: All consecutive patients who underwent transcatheter RVOT
treatment from May 2008 to December 2011 in 4 institutions were studied. 
Results: CC occurred in 6 out of 100 patients (6%) at a median age of
24(13 to 49) years, with RVOT conduit stenosis as the primary lesion in all
cases. The initial congenital heart disease was pulmonary atresia-ventricular
septal defect (n=3), complex transposition of the great arteries (n=2) and
critical aortic stenosis status-post Ross operation (n=1). The RVOT initial
median conduit diameter at surgical implantation was 23(17 to 24) mm and
conduit types were homograft (n=3), bioprothesis (n=2) and a pericardial
patch(n=1). CC was diagnosed by coronary angiogram during balloon dila-
tion of the RVOT in all cases whereas it was suspected on pre-procedure
computed tomography (CT-scan) in only 2 cases. Compression occurred on
the left anterior descending coronary artery in 4 cases and on a right coro-
nary artery that arose from the proximal left anterior descending coronary
artery in 2 patients (single coronary artery). No risk factor was found but
there was a significantly higher incidence of CC in one of the 4th institu-
tions (p=0.04). CC was well-tolerated and resolved after the balloon was
deflated in all the cases. No patients underwent RVOT stenting or PPVI.
Surgical conduit replacement was electively performed in 3 patients. Two
patients with moderate residual RVOT stenosis are followed. One patient
with encephalopathy and respiratory insufficiency died 9 months after
catheterization.
Conclusions: CC is efficiently diagnosed by coronary angiogram during
balloon dilation in a small proportion of patients undergoing transcatheter
interventions on RVOT. Diagnosis by pre procedure CT-scan is not accurate.
No specific risk factors exist. Surgical conduit replacement is indicated when
balloon dilation fails to improve the RVOT obstruction. 
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Cardiac transplantation in adults patients with congenital heart
disease: long-term outcomes and influence of initial defect and repair:
a collaborative study on 97 patients
Sarah Cohen (1), Lucile Houyel (2), Romain Guillemain (1), Shaida Var-
nous (3), Laurence Iserin (1)
(1) Hôpital Européen Georges Pompidou (HEGP), Paris, France –
(2) Centre Chirurgical Marie Lannelongue, Le Plessis-Robinson, France –
(3) Hôpital La Pitié-Salpêtrière, Paris, France
Purpose: Due to increasing success with repair or palliation in childhood,
there is a rapidly growing population of adult patients with complex conge-
nital heart disease who may require transplantation.But ACHD is a heteroge-
neous population. We compared outcomes in different defects and indifferent
physiopathological models of repair i.e. univentricular (1V) or biventricular
(2V) status. 
Methods: Out of a multi-institutional (3 centers) series of 2257 HTx from
1988 and 2012, 100 (4.4%) were performed in 97 ACHD aged ≥16 years at
the time of operation (65 men). We evaluated clinical data, etiology, surgical
history, perioperative issues and outcomes. 
Results: The mean age at the time of HTx was 29.8±10.5 years (range 16-
58). Forty-three patients (44%) had 1V physiology including 16.5% Fontan-
type circulation and 54 (56%) had 2V physiology including 26% with a sys-
temic right ventricle. Primary diagnosis included single ventricle (27%), D-
transposition of the great arteries (20%), tricuspid atresia (13%), tetralogy of
Fallot (12%), congenital valvular heart diseases (11%), corrected transposition
of the great arteries (7%). Twenty-four patients required reintervention for
hemorrhage. In-hospital mortality was high (34%) and multivariable factors
included female gender of the donor and tricuspid atresia. The 1V patients
were younger (26.9 vs 32.1 years, p=0.014), had undergone more surgeries
(2.9 vs 1.9 prior surgeries, p=0.002), had a lower requirement for ventricular
assist device implantation before HTx (4.7% vs 20.4%, p=0.02), and had
longer ischemic (229 vs 182min, p<0.001) and cardiopulmonary bypass times
(240 vs 163min, p<0.001). Long-term survival was significantly higher in 2V
patients (p=0.023). 
Conclusion: HTx of ACHD poses several surgical challenges due to
complex anatomy, specific physiology and prior surgical interventions. 1V
physiology is associated with higher in-hospital and long-term mortality, in
comparison to 2V physiology. 
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TAPSE is correlated with right ventricle ejection fraction in children
with congenital heart disease affecting right ventricular function
Olivier Guillard, Diala Khraiche, Magalie Ladouceur, Laurence Iserin,
Francesca Raimondi, Damien Bonnet
Hôpital Necker Enfants Malades, M3C, Paris, France
Background: In congenital heart disease, assessment of right ventricular
(RV) function is determinant for patient’s follow-up and therapeutic strategy.
However, only few data of RV systolic functioning parameters measured by
echocardiography in children are available, and their usual change in different
types of RV loading condition. We investigated the feasibility, reproducibility
and correlation to 3D RV ejection fraction (RVEF) of each parameter of RV
systolic function in children with congenital heart defect affecting the right
ventricle.
Methods and Results: We performed echocardiography in 143 consecu-
tive children aged 0 to 18 years with different pathological RV loading condi-
tion. We classified them in three groups: dominant volume overload, dominant
barometric overload, and mixed overload. We measured RV systolic function
parameters described in the pediatric and adult literature: Tricuspid Annulus
Posterior Systolic Excursion (TAPSE), Tricuspid Annulus Maximal Systolic
Velocity in Doppler Tissue Imaging (Sa), Fractional Area Change (FAC), 2D
RVEF, 3D RVEF, IsoVolumic Acceleration (IVA) and Tei index. 3D RVEF
was measured using a new system of 2D echography with Knowledge-Based
3D reconstruction allowing to reconstruct volumes from sections of right ven-
tricle with standard sonographer (Ventripoint, USA). This system has been
already validated by MRI volumes measurements.
We found that TAPSE was the most feasible (n=137/143; 97,08%), reproduc-
ible (ICC=0,986;p<0,001)(Coefficient of Variation=2,1%) parameter and was sig-
nificantly correlated to 2D RVEF (R=0,301; p=0,0014) and 3D RVEF (R=O,337;
p=0,0014). Z-score TAPSE age-adjusted is significantly different in each type of
loading condition (Pressure/Volume p=0,0089; Mixed/Pressure p=0,365; Mixed/
Volume p=0,0004). Mixed overload had the worse TAPSE Z-score value (–5) and
volume overload had the best TAPSE Z-score value (–1,5).
Conclusion: We recommend using TAPSE Z-score to assess RV func-
tion in children. However TAPSE is significantly dependent on loading
condition and further studies need to determine range values in each loading
condition (figure next page).
© Elsevier Masson SAS. All rights reserved.
 
Archives of Cardiovascular Diseases Supplements (2014) 6, 95-109 101
297
Atrioventricular discordance with ventriculo-arterial concor-
dance: diagnostic challenge, surgical management and long-term
outcome
Daniela Laux (1), Lucile Houyel (2), Fanny Bajolle (1), Francesca
Raimondi (1), Younes Boudjemline (1), Damien Bonnet (1)
(1) Hôpital Necker Enfants Malades, Cardiologie pédiatrique, Paris,
France – (2) Centre Chirurgical Marie Lannelongue, Le Plessis Robinson,
France
Background: Atrioventricular discordance with ventriculo-arterial concor-
dance is a rare cardiac defect whose pathophysiology resembles transposition
of the great arteries. 
Objective: To report a series of ten patients with atrioventricular discor-
dance with ventriculo-arterial concordance focusing on segmental analysis,
diagnostic difficulties, surgical management and follow-up.
Methods: Monocentric retrospective review of medical files of all patients
with this diagnosis seen from 01.01.1983 to 01.01.2013.
Results: Seven patients had {I,D,S} segmental arrangement, two had ana-
tomically corrected malposition {S,L,D} and one had {S,L,S} arrangement.
Only five patients were correctly diagnosed preoperatively while diagnosis
had to be completed during or after surgery in the other five. Mean age at
repair surgery or at last surgical intervention was 3.4 years (range: 5 months
– 12.8 years). Repair surgery finally performed was atrial switch procedure of
Senning or Mustard type in eight of ten patients. Repair included ventricular
septal defect closure in three cases and right ventricle to pulmonary artery
conduit or patch in four cases. Main postoperative complications were two
cases of baffle obstruction requiring reintervention and one sick sinus syn-
drome needing pacemaker implantation. There was no postoperative heart
block. There were two early postoperative deaths and eight late survivors.
Mean follow-up after repair was 6.8 years (range: 5 months-25.4 years) with
good functional status in all but one patient who will be listed for heart trans-
plantation.
Discussion: Preoperative diagnosis of atrioventricular discordance with
ventriculo-arterial concordance remains challenging. Atrial switch procedure
is the surgical method of choice. If correctly diagnosed, long term follow-up
is encouraging. Rhythm disturbances and baffle obstruction are the main post-
operative problems in this series.
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Premature neonates with severe congenital heart diseases: post opera-
tive course and outcome after early cardiac surgery.
Camille Dollat (1), Virgine Lambert (1), Bertrand Stos (1), Alban Baru-
teau (1), André Capderou (2), Serge Demontoux (1), Michel Hamann (1),
Emir Mokhfi (1), Isabelle Van Aerschot (1), Mathieu Vergnat (1), Emma-
nuel Le Bret (1), Mohamed Ly (1), Regine Roussin (1), Emré Belli (1)
(1) Centre Chirurgical Marie Lannelongue, Cardiologie et Chirurgie Car-
diaque Pédia, Le Plessis Robinson, France – (2) INSERM U999, Le Ples-
sis Robinson, France
Background: Prematurity is a recognized risk factor for morbidity and
mortality following cardiac surgery. This study examined the post-operative
course and the midterm outcome after early cardiac surgery.
Methods: Since 2000, 29 consecutive premature neonates (median GA:
34.4w) were admitted for severe congenital heart disease (at least 2 defects
and/or defect resulting in death within the 1st month of life). All underwent
cardiac surgery with cardiopulmonary bypass in the preterm period; records
were retrospectively reviewed. At surgery, median age was 9d, median cor-
rected GA 36.1w, median weight 2340g; 44% were preoperatively, ventilated.
Pathologies were transposition of the great arteries (n=9), aortic arch obstruc-
tion associated with intra-cardiac defect (n=9), total abnormal pulmonary
venous return (n=5), critical aortic valve stenosis (n=3), univentricular hearts
(n=3); all pts except the latter had a one-stage biventricular repair. 
Results: Thirty-day survival was 86% with 7 early post-operative deaths. Mor-
tality rate raised 66% for pts with univentricular hearts. A low weight at birth and
at surgery and a long delay before sternal closure were risk factors of mortality.
Early outcome was independent of the gestational age, corrected gestational age at
surgery, preoperative status, and duration of both cardiopulmonary bypass and
aortic clamping. Median follow-up of hospital survivors was 15.7 months
(including 11 pts>5 y); 3 pts died after discharge within 5 months post-surgery,
6pts required 8 reoperations for residual cardiac sequellae. At last follow-up, 13pts
were in class I or II of NYHA, 2 had pulmonary artery hypertension.
Conclusion: Cardiac surgery with one-stage biventricular repair for severe
congenital heart diseases is feasible in preterm neonates; mortality is high but
acceptable; the degree of prematurity is not a risk factor of death, which
argues for early surgery. At midterm, there are no late death, a good clinical
status but frequent reoperations.
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Management of anomalous origin of the left coronary artery from the
pulmonary artery (ALCAPA) syndrome during adulthood: a multi-
center retrospective study in a serie of twelve patients.
Laura Le Berre Dherbécourt (1), Jacques Mansourati (1), Alain Fraisse (2),
Dominique Boulmier (3), Bruno Gallet (4), François Godart (5), Patrice
Guerin (6)
(1) CHU Brest, Cardiologie, Brest, France – (2) Hôpital la Timone, Cardio-
logie Pédiatrique, Marseille, France – (3) CHU Rennes – Hôpital Pont-
chailloux, Cardiologie, Rennes, France – (4) CH Victor Dupouy, Argenteuil,
France – (5) CHR Lille, Lille, France – (6) CHU Laennec, Nantes, France
ALCAPA syndrome is a rare congenital heart disease, mainly diagnosed
during the first months of life, with a high early mortality in the absence of
surgery in symptomatic children. Adult form is extremely rare and no recom-
mendation for its management is available. We undertook this study in order
to analyze symptoms, management and long term outcome of adult patient
with ALCAPA.
Methods: we analyzed retrospectively the data of patients who have been
hospitalized in Cardiology Departments of 7 French Hospitals.
Results: 12 adults(30.2±21.4 years) were included. Main symptoms
consisted of chest pain(58.3%), supra-ventricular arrhythmia(42.9%) and heart
failure(33.3%). ECG was abnormal in 60%(negative T waves or ST segment
depression). Echocardiogram showed a mean LVEF of 51.5±12.8% and mitral
regurgitation was present in 83.3% of the cases(mainly moderate). Coronary
angiography was performed in 83.3% of patients and showed ALCAPA in all
cases. CT-scan, MRI and myocardial scintigraphy were also performed
(respectively in 45.5%,27.3% and 41.7%), as well for diagnosis as for follow-
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up. 11 patients underwent reconstructive surgery, with mitral valve reconstruc-
tion in one case. 1 patient refused surgery and died 2 years later. Immediate
post-operative complications were cardiogenic shock(2 patients), one non-
significant narrowing of the transferred coronary artery ostium that was
treated medically and in 1 case, a significant stenosis of the pulmonery artery
trunk and of the LCA required surgery. A prophylactic ICD was implanted in
1 patient. All operated patients are alive with a follow-up of 16.9±22 years.
Conclusion: diagnosis of ALCAPA in adult is done mainly by coronary
angiography in the presence of atypical symptoms. The long term results of
surgery are excellent. Based on the complicated evolution of this syndrome
and the good results of surgery, it should probably be proposed systematically
even in case of accidental discovery in an asymptomatic adult. 
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Prognosis of severe congenital heart diseases: do we overestimate the
impact of prenatal diagnosis?
Marie Vincenti (1), S. Guillaumont (2), Gregoire Mercier (3), Grégoire De
La Villeon (1), Charlène Bredy (1), Arnaud Bertrand (1), M. Voisin (4),
Gilles Cambonie (5), Pascal Amedro (1)
(1) CHU Arnaud de Villeneuve, Cardiologie Pédiatrique et Congénitale,
Montpellier, France – (2) Institut Saint-Pierre, Cardiopédiatrie, Palavas-Les-
Flots, France – (3) CHU Montpellier, Epidémiologie et Recherche Clinique,
Montpellier, France – (4) CHU Arnaud de Villeneuve, Cardiopédiatrie, Mont-
pellier, France – (5) CHU, Néonatalogie, Montpellier, France
Introduction: congenital heart diseases (CHD) are the most common and
serious among birth defects (incidence 0.8%). Prenatal screening is time-
consuming and costly in terms of organization. It is subject to controversy
because of unproven benefits on morbidity and mortality associated with a
significant impact on the continuation of the pregnancy.
Method: from 2003 to 2009 we retrospectively analyzed all pregnancies
and children aged less than 1 with a diagnosis of CHD in our tertiary center
database. Our study population was then limited to serious or complex CHD:
lethal cases, leading to medical termination of pregnancy (MTP), and CHD
requiring surgery, interventional catheterization or hospitalization during the
first year of life. Primary endpoint was 1-year mortality among alive neonates.
Results: 322 severe CHD were included. 62.1% had a prenatal diagnosis
with an excellent screening predictability of the heart defect severity. We
observed significant differences between prenatal (group 1) and postnatal
(group 2) CHD diagnoses comparing: type of heart disease (hypoplastic left
heart syndrome 7.8% vs. 0.8%), frequency of ductal-dependent heart defect
(34.3% vs. 28.7%) and association with chromosomal abnormality or malfor-
mation syndrome (31.1% vs. 28.8%). We counted 96 MTP of 200 prenatal
diagnosis (48%). Among the 224 alive neonates 15.2% died before the age of
1. Mortality at 1 year and major prognosis morbidity variables were not
significantly different in both groups.
Conclusion: in our center prenatal diagnosis of severe CHD has an impact
on the decision of MTP but not on prognosis in terms of 1-year mortality and
morbidity. We recommend prospective multicenter studies with assessment of
neurological prognosis and quality of life of patients. These studies will be
facilitated by the use of standardized CHD registries.
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Impact of antenatal diagnosis on outcomes of neonates with hypoplas-
tic left heart syndrome
Magali Veyrier, Hervé Joly, Nicolas Pangaud, André Bozio, Sylvie Di
Fillipo
Hôpital Cardiovasculaire, Cardiologie Pédiatrique et Congénitale, Lyon,
France
The objective of this study was to assess the influence of antenatal diag-
nosis of HLHS on postnatal outcomes.
Material and methods: This is a retrospective review of French single-
centre records of neonates with diagnosis of HLHS. Clinical data, therapeutic
management, outcomes were assessed. Comparison were made between
groups with and without antenatal diagnosis, and between periods before and
after 2005 (date of initiation of Norwood Program).
Results: Among 95 neonates (56 males= 59%) with HLHS, 44 (46%) were
diagnosed prenatally (PreND group) and 51 (53%) after birth (PostND group).
Birth weight was 3±0.5kg, Age at diagnosis in PostND group was 4±6 days.
All patients were free from symptom in the PreND group, while PostND
group cases presented with heart failure (42%), cardiogenic shock (24%), cya-
nosis (12%), heart murmur (8%) or associated symptoms (14%). Age at Nor-
wood procedure was 6±2 days in PreND and 9±4 days in PostND (p= 0.01).
Time from diagnosis to surgery did not differ between groups (mean 6 days).
Survival was similar between groups. Because of less termination of pre-
gnancy, 71% (22 of 31 cases) of neonates with HLHS were diagnosed prena-
tally since 2005, compared with only 34% (22 of 64) before 2005 (p< 0.01).
Conclusion: Antenatal diagnosis may prevent acute postnatal cardiac
failure in neonates with HLHS and allow early Norwood procedure, but it
does not impact on long-term postoperative outcome.
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Echocardiographic right ventricular function variables: external vali-
dity study in a normal pediatric population 
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Vincenti (1), Charlène Bredy (1), Grégoire De La Villeon (1), Arnaud
Bertrand (1), M. Voisin (4), Pascal Amedro (1)
(1) CHU Arnaud de Villeneuve, Cardiologie Pédiatrique et Congénitale,
Montpellier, France – (2) Institut Saint-Pierre, Cardiopédiatrie, Palavas-
Les-Flots, France – (3) CHU Montpellier, Epidémiologie et Recherche
Clinique, Montpellier, France – (4) CHU Arnaud de Villeneuve, Cardio-
pédiatrie, Montpellier, France
Introduction: regular echocardiographic assessment of right ventricular
(RV) function is required in patients with congenital heart disease (CHD).
Although normal values are validated in the adult population, few studies are
published in pediatrics. The aim of this study is to define in real clinical situ-
ation normal values for RV variables in children and to compare the results to
published studies.
Methods: prospective multicenter study from 2010 to 2012. 314 normal chil-
dren aged 2 days to 18 years included (46% female, 88 infants under 1 year old,
26 neonates, 226 children). Following RV variables were collected by 4 pediatric
cardiologists, using 2 ultrasound systems (Philips IE33, Aloka Alpha 10): tissue
Doppler imaging (TDI) E’, A’ and S waves at tricuspid valve, TDI Tei Index and
TAPSE. The impossibility to measure a variable was informed. A univariate poly-
nomial linear regression was used to assess the relationship between these indexes
and the anthropometric factors via the coefficient of determination.
Results: more than 90% variables could be easily collected. Mean values for
E’, A’ and S waves were: 13,7 ± 3,8 cm/s, 10,1 ± 3,7 cm/s, and 12 ± 2,2 cm/s;
mean values for TAPSE were 18,7 ± 4,9 mm and 0,41 ± 0,11 for DTI Tei index.
In infant, E’, A’ and S waves were best correlated with BSA, and TAPSE with
height. In children S wave and TAPSE were best correlated with weight, and A’
with age. No significant correlation was found for E’ wave in children, and for
DTI Tei index. No significant differences were found between genders, ultrasound
systems. Values were mostly well correlated to published studies.
Conclusion: we established echocardiographic RV function reference
values in children with good feasibility and correlation to published reference
studies. Routine application to children with CHD must be defined.
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Feasibility and reproducibility of tissue motion annular displacement
of mitral valve in children with and without heart disease
Sebastien Hascoët (1), Virginie Chelini (2), Peyre Marianne (1), Yves
Dulac (1), Khaled Hadeed (1), Philippe Acar (1)
(1) CHU Toulouse, Hôpital des enfants, Cardiopédiatrie-Pr Acar, Toulouse,
France – (2) CH Martigues, Cardiologie-Dr Yvorra, Martigues, France
Objectives: Little is known about parameters of systolic left ventricular
(LV) function using speckle tracking (ST) in children. The aim of this study
© Elsevier Masson SAS. All rights reserved.
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was to define the feasibility (F) and reproducibility (R) of tissue motion
annular displacement of mitral valve (TMAD) in healthy children (HC), in
children with heart disease (HD) and to assess the correlations between
TMAD and usual LV systolic function parameters. 
Methods: We prospectively included 22 children with HD (13 boys, mean
age 104 months) and 22 HC (12 boys, mean age 116 months). In an apical
4 chambers view 1 region of interest (ROI) was placed at the septal and lateral
parts of the mitral annulus and 1 at the apex. The displacement of the midpoint
between the 2 annular ROIs toward the apex was calculated by QLAB 9® soft-
ware. 
Results: TMAD indexed F was 100% (CI95% 94,8-100%) in children with
and without HD and 86% (CI95% 71,5-100%) in HC. F of TMAD was not
significantly different between HC and children with HD. Intra observer vari-
ability (V) of TMAD was respectively 19% and 11% in HC and in children
with HD. Inter observer V of TMAD was respectively 19% and 16% in HC
and in children with HD. TMAD was not correlated to age nor to body surface
area (BSA) nor to LV ejection fraction in HC whereas indexed TMAD was
correlated to stroke volume (r=0,591, p=0,0122), cardiac index (r=0,532,
p=0,0241), indexed TAPSE (r=0,691, p=0,0034) and conversely correlated to end-
diastolic (ED) LV diameter (r=–0,677, p=0,0041), to EDLV volume (r=–0,629,
p=0,0076) and to end-systolic LV volume (r=-0,616, p=0,0090) in HC. 
Conclusion: TMAD seems an easy measurable marker with an excellent F
and R to assess the mitral annular displacement. It seems independent of BSA
and well correlated with stroke volume. The advantage of TMAD over Tissue
Doppler imaging relies on the independence on angle. TMAD is an interesting
tool in children. Its accuracy to estimate systolic function needs to be further
investigated in children.
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Folded melody valve technique for complex right ventricular outflow
tract
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Damien Bonnet (1), Younes Boudjemline (1)
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Introduction: Percutaneous Melody valve implantation has achieved stan-
dard of care for the management of patients with dysfunctional right ventricle
(RV) to pulmonary artery (PA) conduits. The landing zone right ventricular
outflow tract (RVOT) dimensions may vary significantly making it unfavor-
able for Melody valve implantation. We report a novel technique in patients
with complex RVOT anatomies.
Methods: All patients were candidates for Melody insertion were evalu-
ated with angiography. The landing zone was carefully studied. Patients with
short landing zone or landing zone consisting of a retrosternal part were
valved using a special technique. In patients with short landing zone, there
was a risk of Melody valve impingement with the RV muscle at the proximal
end and the risk of accidental covering of PA distally. To circumvent these
potential complications, we modified the Melody valve before implantation.
The terminal open stent struts of the Melody valve were folded over itself
from inside out to reduce its effective length. 
Results: From 2008 to 2012, four patients received a shortened Melody.
The uncovering, crimping and loading of the Melody valve was technically
simple in all. The folded and crimped valve moved easily in the delivery
system and the deployment was done using standard technique. All valves
were positioned where intended. Patients were discharged the day after the
procedure. Evaluation showed excellent performance of the Melody valve
with no paraprosthetic leak, no erosion, no perforation, no stent fracture, no
residual stenosis, no valvular or para valvular regurgitation immediately after
implantation or at follow up. 
Conclusion: The “Folded valve technique” is a safe addition to the inter-
ventional armamentarium allowing the implanting physician to modify the
valve in patients with complex RVOTs. In the future, this technique may also
be an option for patients with vulnerable RVOT neighborhood that may pre-
clude conventional technique. 
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Anomalous left coronary artery from the pulmonary artery associated
with other cardiac defects: a difficult joint diagnosis
Daniela Laux (1), Claire Bertail (2), Fanny Bajolle (1), Lucile Houyel (2),
Younes Boudjemline (1), Damien Bonnet (1)
(1) Hopital Necker Enfants Malades, Cardiologie pédiatrique, Paris, France
– (2) Centre Chirurgical Marie Lannelongue, Le Plessis Robinson, France
Background: Anomalous left coronary artery connected to the pulmonary
artery (ALCAPA) is a coronary abnormality which can be associated to other
congenital heart defects which complicates the positive diagnosis especially
before surgery. 
Objective: Here we report a series of 13 patients with ALCAPA with a
focus on the type of associated heart defect, the moment of diagnosis of the
coronary abnormality related to surgery and their outcome. 
Methods: Retrospective assessment of medical files of all patients with
ALCAPA and other congenital heart defects in two important French Depart-
ments of Pediatric Cardiac Surgery from 1987 to 2012.
Results: The heart defect most frequently encountered in association to
ALCAPA was aortic coarctation (n=5) followed by tetralogy of Fallot with or
without pulmonary atresia (n=3). There was one case of hypoplastic left heart
syndrome, one aortic atresia, one right aortic arch, one congenital mitral malfor-
mation and one infant with divided left atrium and partial anomalous pulmonary
venous return. Only four patients had a complete diagnosis of the cardiac defect
and the coronary abnormality before surgery. In three cases the coronary
anomaly was discovered during surgery conducted for another cardiac defect
and treated at the same time by coronary reimplantation. The six remaining
patients were diagnosed after cardiac repair. Three of these patients only had a
post-mortem diagnosis. Eight of 13 patients died after surgery. Three of them
deceased within the first 30 days after repair. The remaining patients are in good
health with a median follow-up of 5.3 years (range: 2.1–8.5 years). 
Discussion: This series confirms that ALCAPA associated with other car-
diac defects is often misdiagnosed before surgery. Pulmonary hypertension
due to left-to-right shunt or coarctation can maintain an anterograde flow in
the anomalous coronary artery until cardiac repair. Myocardial ischemia will
only become apparent once the defect has been repaired when pulmonary
pressure lowers. In this series postoperative survival was compromised mostly
due to complications occurring after complex or repeated cardiac surgery.
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Surveillance of pediatric heart transplant patients in France: a natio-
nal survey
Pierre-Emmanuel Séguéla (1), Karine Nubret-Le Coniat (1), Lucile
Houyel (2), Sylvie Di Filippo (3), Franck Iserin (4), Yves Dulac (5), Lau-
rianne Le Gloan (6), Béatrice Bonello (7), Eric Epailly (8), Florentine
Garaix (7), Arnaud Garnier (5), Jean-Benoit Thambo (1), Philippe Mauriat (1)
(1) CHU Bordeaux-Hôpital Haut-Lévèque, Cardiologie Pédiatrique et
Congénitale, Pessac, France – (2) Centre Chirurgical Marie Lannelon-
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Toulouse, France – (6) CHU Nantes, Nantes, France – (7) CHU Mar-
seille, Marseille, France – (8) CHU Strasbourg, Strasbourg, France
Introduction: Rejection following cardiac transplant remains a important
cause of morbidity and mortality as well as the complications of immunosup-
pressive therapy. Thus, surveillance of pediatric heart transplant (PHT)
patients is crucial to prevent these risks or, at least, to allow an early
treatment. However, very few international guidelines have been established
concerning the modalities of this monitoring. 
Aims: To collect and to compare the different practices of PHT surveil-
lance in France. 
Patients and Methods: Descriptive multicenter study. Each french cardio-
logic center involved in PHT was contacted by e-mail in order to complete an
electronic questionnaire. 
Results: 8 centers were involved in the surveillance (including 7 centers
performing PHT) of these patients. The average number of followed PHT
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patients was 16.1 (2-50) per center. The average number of involved physi-
cians was 3.7 (1-8) including 38% of pediatric cardiologists. Only two centers
had a devoted nurse for this activity. Echocardiography was considered to be
reliable for the early detection of transplant rejection by only 57% of centers.
IVRT was always collected. Whereas TM measurements were frequently ana-
lyzed, other Doppler measurements were inconsistently reported. Myocardial
strain analysis (using speckle tracking method) was almost never performed
(14%). Coronarography was systematically performed in 43%, coronary CT
angiogram in 28% and cardiac MRI in 14%. For patients aged > 1 year, car-
diac biospies were systematically performed in 86%. The prevention of the
transplant coronary artery disease was conducted using pravastatin in 86%,
aspirin in 28% and clopidogrel in 14%. 
Conclusion: The French practices for the monitoring of PHT patients are
highly heterogeneous due to the absence of national recommendations. This
study highlights the need of a national register in order to establish consen-
suses for the management of these patients.
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Xavier Iriart (1), Nadir Tafer (2), François Roubertie (3), Beatrice Roux (2),
Karine Nubret (2), Charlotte Sgro (2), Philippe Mauriat (1), Jean-Benoit
Thambo (1)
(1) CHU Bordeaux, Service des cardiopathies congénitales, Pessac, France –
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Background: Transesophageal echocardiography (TEE) has become a
critical diagnostic and perioperative management tool for patients with
congenital heart disease. The use of dedicated paediatric TEE probes is how-
ever not recommended in children below 5 kg which make it not available for
neonatal cardiac surgery. 
Aim: To assess the feasability and the quality of imaging modalities of a
new micro multiplane transoesophageal echocardiogram probe during repair
of congenital heart defects in neonates. 
Method: Prospective study of micro transoesophageal echocardiogram S8-
3t probe used at a single institution.
Results: A total of 15 perioperative studies were performed on 15 patients,
with a median weight of 3.52 kilograms (2.7–4.5 kg) and a median age of
34 days (2 -150 days). We experienced none of the usual complications
related to probe insertion including difficulty with probe insertion, airway
compression, displacement of an endotracheal tube or damage to surrounding
structures. We obtained good two-dimensional imaging quality in all patients.
Pulse wave and continuous wave Doppler was consistently good across all
examinations allowing complete pre and post-operative assessment of cardiac
anatomy and function.
Conclusion: The use of micro multiplane transoesophageal echocardio-
gram probe is safe and feasible, and provides imaging of good quality in neo-
nates. It may become an additional tool in routine for the surgical management
of neonates with complex congenital heart defects.
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lous pulmonary venous connection. A transcatheter closure series of
5 further cases.
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The vertical vein (VV) is frequently left non ligated after supracardiac
TAPVC rechanneling, to avoid hemodynamic complications due to small left
heart especially in case of obstructed connection.
Objective: We report here one centre experience in TAPVC rechanneling,
and follow up of the VV.
Patients and methods: We have done a retrospective study to illustrate the
outcome of supracardiac TAPVC since 1998. VV follow up was performed by
colour-Doppler echocardiography and CT scan. Transcatheter closure of VV
was performed under local anaesthesia.
Results: We had a total of 11 patients (7 males and 4 females). Diagnosis
was done between the age of 1 and 120 days, all of them had undergone
rechanneling. VV was not ligated in 4 out of 5 patients with obstructed
connection with partial ligation in one of them, versus 3 out of 6 patients
without obstruction. VV patency had no immediate post operative benefits in
non obstructed TAPVC. On the opposite in obstructed connection, the ligation
was associated with longer ICU stay duration as observed in our sole patient
(33 days).
During follow-up, VV remained patent in 6 of 7 patients and required
transcatheter closure in 5 patients because of significant left to right
shunt. The shunt was negligible in the remaining patient who had partial
ligation.
The closure was successfully performed without complications with Amp-
lazer Vascular Plug (type 2) at a median age of 4 years and 8 months. The
device diameter was chosen up to 1.5 fold of the diameter of VV. The radia-
tion doses ranged between 2 to 17 Gycm2. After closure, VV occlusion was
confirmed in all patients. 
Conclusion: Patent VV in non obstructed TAPVC does not change post
operative course. Partial ligation may be considered in obstructed TAPVC.
Most non ligated VVs remain patent. Transcatheter occlusion with Amplazer
Vascular Plug is a safe and effective procedure to suppress the left to right
shunt. 
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Introduction: In discrete fixed subaortic stenosis, surgery is indicated
when the systolic gradient (Gmax) between the left ventricle (LV) and the
aorta exceed 50 mmHg or in the presence of significant aortic regurgitation
(AR). 
The aim of this study is to determine the factors that influence the progres-
sion of the obstruction and the appearance of AR. 
Methods: retrospective serial echocardiographic review of 19 patients,
mean age 16 years (2 years-38 years), with fixed discrete subaortic ste-
nosis that don’t require surgery ( initial Gmax at inclusion <50 mmHg and
without any symptom). The mean follow up was 5,42 years. The progres-
sion of gradient is defined by the formula (Gmax at follow up – initial
Gmax)
Results: the mean velocity of increasing of Gmax was 2 mmHg/year.
This progression was correlated to the patient’s age (cut off=15 years, r=–0,5
p=0,02), and the initial value of the Gmax (cut off=40 mmHg, r=0,43;
p=0,04).
The appearance or the aggravation of aortic regurgitation was determined
by: the initial grade of AR (r=0,64 ; p=0,003), initial Gmax (r=0,65; p=0,002),
progression’s velocity of G max (r=0,47; p=0,04), and distance between the
membrane and the aortic cusps (cut off=5 mm, r=0,49 ; p=0,03).LV hyper-
trophy was influenced by the velocity of progression of obstruction
(>2 mmHg/year)
Conclusion: the identification of factors determining the evolution of dis-
crete subaortic stenosis (age < 15 years, initial Gmax > 40 mmHg, distance
membrane- cusps > 5 mm) allow an adequate screening of patients that will
require early operation.
